BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/25/2025 3:51:27 AM | Browse: 1 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Qushi Huoxue ointment ameliorates metabolic associated steatotic liver disease through autophagy activation and ferroptosis inhibition
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Yang Liu, Hong Qin, Hong-Xi Wu, Ru-Ting Wang, Qiu-Yan Yang, Feng Jiang, Xu-Dong Liu, De-Kun Wu and You-Ming Tang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (General Program) |
82160837 |
| Huatong Guokang Medical Research Special Project Grant |
2023HT026 |
| Innovation Project of Guangxi Graduate Education |
YCSW2024405 |
|
| Corresponding Author |
De-Kun Wu, Teaching Experiment and Training Center, Guangxi University of Chinese Medicine, No. 179 Mingxiu East Road, Xixiangtang District, Nanning 530011, Guangxi Zhuang Autonomous Region, China. 1278323777@qq.com |
| Key Words |
Metabolic associated steatotic liver disease; Qushi Huoxue ointment; Autophagy; Ferroptosis; Lipid deposition |
| Core Tip |
Qushi Huoxue ointment can alleviate hepatic lipid accumulation, inflammation, and cell injury in metabolic associated steatotic liver disease mice. Our experimental evidence suggests that these therapeutic effects may be attributed to the concurrent activation of autophagy and inhibition of ferroptosis. The improvement in mitochondrial morphology and the presence of autophagosomes observed under the microscope provide morphological corroboration for this coordinated mechanism. |
| Citation |
Liu YY, Qin H, Wu HX, Wang RT, Yang QY, Jiang F, Liu XD, Wu DK, Tang YM. Qushi Huoxue ointment ameliorates metabolic associated steatotic liver disease through autophagy activation and ferroptosis inhibition. World J Hepatol 2025; In press |
 |
Received |
|
2025-11-03 07:13 |
 |
Peer-Review Started |
|
2025-11-03 07:14 |
 |
First Decision by Editorial Office Director |
|
2025-11-10 07:02 |
 |
Return for Revision |
|
2025-11-10 07:02 |
 |
Revised |
|
2025-11-23 14:20 |
 |
Publication Fee Transferred |
|
2025-11-24 15:18 |
 |
Second Decision by Editor |
|
2025-12-24 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-25 03:51 |
 |
Articles in Press |
|
2025-12-25 03:51 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345